Tal Grenader
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- PARP inhibition in cancer therapy
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 15
- Inflammatory Biomarkers in Disease Prognosis 9
-
- Prostate Cancer Treatment and Research 4
- Metastasis and carcinoma case studies 4
- Renal cell carcinoma treatment 3
- Co-authors
- Linda Shavit (28 shared papers)Alberto Gabizón (13 shared papers)Hilary Shmeeda (3 shared papers)John A. Bridgewater (6 shared papers)Maya Gips (4 shared papers)Tamar Peretz (6 shared papers)Stephen Nash (3 shared papers)Meyer D. Lifschitz (5 shared papers)
- Journals
- Anti-Cancer Drugs (8 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (3 papers)European Journal of Internal Medicine (3 papers)The Annals of Thoracic Surgery (2 papers)
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Tal Grenader
64 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Oncology 327
- Biomaterials 140
- Dermatology 50
- Pulmonary and Respiratory Medicine 137
- Drug Discovery 1
Countries citing papers authored by Tal Grenader
This map shows the geographic impact of Tal Grenader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Grenader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Grenader more than expected).
Fields of papers citing papers by Tal Grenader
This network shows the impact of papers produced by Tal Grenader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Grenader. The network helps show where Tal Grenader may publish in the future.
Co-authors
The 25 scholars most cited alongside Tal Grenader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 101 | |
| 2 | 2016 | 92 | |
| 3 | 2011 | 80 | |
| 4 | 2015 | 63 | |
| 5 | 2016 | 61 | |
| 6 | 2017 | 61 | |
| 7 | 2015 | 54 | |
| 8 | 2017 | 43 | |
| 9 | 2012 | 38 | |
| 10 | 2007 | 31 | |
| 11 | 2014 | 31 | |
| 12 | 2011 | 28 | |
| 13 | 2008 | 27 | |
| 14 | 2017 | 27 | |
| 15 | 2012 | 26 | |
| 16 | Aortic occlusion in patients treated with Cisplatin-based chemotherapy. | 2006 | 22 |
| 17 | 2005 | 20 | |
| 18 | 2008 | 20 | |
| 19 | 2009 | 20 | |
| 20 | 2003 | 18 |
About Tal Grenader
Tal Grenader is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Physiology and Emergency Medical Services, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Alzheimer's disease research and treatments (5 papers), Breast Cancer Treatment Studies (5 papers), Prostate Cancer Treatment and Research (4 papers), Metastasis and carcinoma case studies (4 papers), Central Venous Catheters and Hemodialysis (3 papers), BRCA gene mutations in cancer (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Oncology (327 citations), Biomaterials (140 citations), Dermatology (50 citations), Pulmonary and Respiratory Medicine (137 citations) and Drug Discovery (1 citation). Tal Grenader has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Linda Shavit, Alberto Gabizón, Hilary Shmeeda, John A. Bridgewater, Maya Gips, Tamar Peretz, Stephen Nash, Meyer D. Lifschitz, Naureen Starling and J. R. Oates. Their work appears in journals such as Anti-Cancer Drugs, Annals of Oncology, Journal of Clinical Oncology, European Journal of Internal Medicine and The Annals of Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.